Breaking News
Get 45% Off 0
Investors lost 37% by missing this ONE signal 😵
Read now

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
Look At Fidelity Advisor Emerging Asia C Fund (FERCX) By Zacks Investment Research - Nov 07, 2017

Fidelity Advisor Emerging Asia C Fund FERCX seeks to provide growth of capital in the long run. FERCX invests the lion’s share of its assets in securities of companies from the emerging markets...

Zacks Investment Research
MGM Resorts' (MGM) Q3 Earnings Meet Estimates, Revenues Beat By Zacks Investment Research - Nov 07, 2017

MGM Resorts International (NYSE:MGM) posted adjusted earnings of 33 cents per share, which came in line with the Zacks Consensus Estimate. However, the bottom-line declined 43.1% on a year-over-year...

Zacks Investment Research
Denbury (DNR) Posts Earnings In Q3, Retains Capital View By Zacks Investment Research - Nov 07, 2017

DenburyResources Inc. (NYSE:DNR) reported strong third-quarter 2017 results, courtesy of higher oil equivalent price realizations.The upstream company’s earnings – after adjusting for...

Zacks Investment Research
AVEO Pharmaceuticals Q3 Loss Narrows, Focus On Fotivda By Zacks Investment Research - Nov 07, 2017

AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) reported a third-quarter 2017 adjusted loss of 2 cents per share (excluding loss due to change in fair value of warrant liability), narrower than the Zacks...

Zacks Investment Research
Snap (SNAP) Q3 Loss Widens Y/Y, Revenues Miss Estimates By Zacks Investment Research - Nov 07, 2017

Snap Inc. (NYSE:SNAP) reported loss per share of 14 cents, in line with the Zacks Consensus Estimate but wider than the year-ago quarter’s loss of 13 cents.The company reported revenues of...

Zacks Investment Research
Cable ONE (CABO) Q3 Earnings Top, Revenues Lag Estimates By Zacks Investment Research - Nov 07, 2017

Cable ONE Inc. (NYSE:CABO) reported mixed financial results in the third quarter of 2017. The bottom line surpassed the Zacks Consensus Estimate, while the top line missed.Net IncomeQuarterly net...

Zacks Investment Research
Arena Pharmaceuticals (ARNA) Q3 Loss Widens Y/Y, Sales Beat By Zacks Investment Research - Nov 07, 2017

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported a loss of 86 cents per share in the third quarter of 2017, wider than the year-ago loss of 51 cents. The Zacks Consensus Estimate was pegged at a...

Zacks Investment Research
Company News For Nov 8, 2017 By Zacks Investment Research - Nov 07, 2017

Shares of Avis Budget Group, Inc. (NASDAQ:CAR) fell 15.1% after reporting third-quarter revenues of $2,752 million, missing the Zacks Consensus Estimate of $2,776 millionValeant Pharmaceuticals...

Zacks Investment Research
Stock Market News For Nov 8, 2017 By Zacks Investment Research - Nov 07, 2017

Benchmarks closed mixed on Tuesday with the Dow finishing at new highs and the S&P 500 and the Nasdaq ending in the red. Weak profit forecasts from both Priceline and TripAdvisor pulled the...

Zacks Investment Research
Humana (HUM) Beats Q3 Earnings Estimates, Revenues Miss By Zacks Investment Research - Nov 07, 2017

Humana Inc.’s (NYSE:HUM) third-quarter 2017 operating earnings per share of $3.39 beat the Zacks Consensus Estimate by approximately 3.7%. The bottom line improved 6.6% year over year driven...

Zacks Investment Research
Mack-Cali (CLI) Q3 FFO Misses Estimates, Revenues Up Y/Y By Zacks Investment Research - Nov 07, 2017

Mack-Cali Realty Corp. (NYSE:CLI) reported third-quarter 2017 core funds from operations (FFO) per share of 57 cents, missing the Zacks Consensus Estimate by a penny. However, the figure compared...

Zacks Investment Research
IPO Market Hot This Week: ETFs To Tap By Zacks Investment Research - Nov 07, 2017

The U.S. IPO market is sizzling this week with 11 deals that will collectively raise more than $2 billion. This will mark the busiest week of this year. In particular, the Chinese companies have been...

Zacks Investment Research
Prothena (PRTA) Earnings Beat In Q3, Pipeline In Focus By Zacks Investment Research - Nov 07, 2017

Prothena Corporation plc (NASDAQ:PRTA) reported a loss of $1.37 per share in the third quarter of 2017, narrower than the Zacks Consensus Estimate loss of $1.41 but wider than the year-ago loss of...

Zacks Investment Research
Pilgrim's Pride (PPC) Beats On Q3 Earnings And Revenues By Zacks Investment Research - Nov 07, 2017

Premium consumer goods company Pilgrim's Pride Corporation (NASDAQ:PPC) reported better-than-expected results for third-quarter 2017. The company is poised to grow on the back of its diversified...

Zacks Investment Research
Is Western Digital (WDC) A Great Stock For Value Investors? By Zacks Investment Research - Nov 07, 2017

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are...

Continue with Apple
Continue with Google
or
Sign up with Email